The FDA review for Sarepta is coming up next week, and I'm curious if anyone has any insights that could impact the ANP study.
It's possible that if the result is negative, there could be a pump-and-dump situation. Alternatively, the stock price could gradually decline before taking off.
The choice is yours. Good luck!
- Forums
- ASX - By Stock
- PER
- For General Information
For General Information, page-2041
-
- There are more pages in this discussion • 1,486 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.92M |
Open | High | Low | Value | Volume |
8.0¢ | 8.2¢ | 8.0¢ | $111.7K | 1.386M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 31160 | 8.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.2¢ | 21976 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 12209 | 0.082 |
1 | 31160 | 0.081 |
1 | 42922 | 0.080 |
1 | 25278 | 0.079 |
2 | 30620 | 0.078 |
Price($) | Vol. | No. |
---|---|---|
0.082 | 21976 | 1 |
0.083 | 100000 | 1 |
0.084 | 160250 | 2 |
0.085 | 168500 | 2 |
0.086 | 291111 | 3 |
Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online